Board of directors
Dr. Albert D. Friesen Co-Founder & Chairman, Miraculins Inc.
A successful entrepreneur, Dr. Albert Friesen has been instrumental in the founding and early stage development of several biopharmaceutical and biotechnology companies in North America including Winnipeg Rh Institute, WinRho, ABI Biotechnology, Viventia Biotech Inc., Genesys Pharma Inc., KAM Scientific Inc. and Medicure Inc. Dr. Friesen is currently the president and CEO of Medicure Inc. He has an extensive network within the international biotechnology and corporate finance communities.
Dr. Friesen's notable achievements include the establishment of several GMP (Good Manufacturing Process) facilities for the production of human pharmaceuticals, as well as the initiation and management of the research and clinical development of numerous pharmaceutical candidates including more than 15 INDs (Investigational New Drug Application) and 2 successful NDAs (New Drug Application). He was the co-founder, first chairman of the Industrial Biotechnology Association of Canada and has been a member of the Industrial Advisory Committee to the Biotechnology Research Institute in Montreal.
Dr. Friesen is the recipient of a number of awards including Distinguished Alumni, University of Manitoba and the Order of Manitoba. He holds a B.Sc. (Hon.), M.Sc. and a PhD in Protein Chemistry from the University of Manitoba.
Dr. Phiet T. Bui Co-Founder & Chief Scientific Officer
Dr. Phiet Bui is an independent pharmaceutical and biotechnology industry consultant based in Irvine, California. Dr. Bui was an early employee with Amgen before serving as director of process engineering for Xoma Corporation. As a consultant, he has served several internationally recognized corporations including SmithKline, Dow Chemical, Celtrix Pharmaceuticals Inc., Jacobs Engineering, Ingene and Ehrlich Rominger Engineering.
Dr. Jim Charlton
Dr. Charlton is the former president of Miraculins Inc., as well as a previous vice-president of research for Medicure Inc. Earlier in his career he was a professor in the Department of Chemistry, University of Manitoba, where he focused on asymmetric organic synthesis and medicinal/pharmaceutical chemistry. Dr. Charlton has also held sisiting Scientist status at a number of institutions, including Bio-Mega/Boehringer Ingelheim Canada, in Montreal, where he contributed to the medicinal chemistry of antiviral compounds and worked with a group preparing drug candidates.
Dr. Charlton obtained his PhD in Chemistry from the University of Western Ontario.
Peter de Visser
Peter de Visser is the founding partner of De Visser Gray Chartered Accountants, a Vancouver based accounting firm. He has been in public practice for well over 20 years. Mr. de Visser has considerable experience as director of publicly traded companies, and was formerly the chief financial officer of Medicure Inc.
Mr. De visser holds a Bachelor of Commerce from the University of British Columbia and is a Chartered Accountant.
Ted Paetkau
Ted Paetkau is the president of Concord Projects Ltd., a contracting firm in Winnipeg, Manitoba with expertise in all areas of general contracting, construction management, project coordination and engineering.
A professional engineer, Mr. Paetkau has worked in the construction industry since 1972 and founded Concord Project Ltd. in 1978.